Pharmacokinetic Studies of Naringenin and Hesperetin in Human Plasma after Oral Administration of Zhizhu Wan
Wang Xi-jun, Xi Chen
Abstract
Wang Xi-jun, Xi Chen
Abstract
Objective:Elucidating the pharmacokinetic properties of Zhizhu Wan.Method:By using β-Glucuronidase,free hesperintin and naringenin were obtained from the hesperetin-glucronide naringenin-glucronaide in plasma,the contents of the two compounds in plasma was determined by HPLC.Results:T1/2(ka)/T1/2(ke)(h) for naringenin and hesperetin are 2.142±0.999/5.491±3.926 and 2.106±0.728/5.824±3.067 respectively,and the AUC(mg/L·h) value are 34.886±22.199 and 39.407±19.535 for naringenin and hesperetin respectively.Conclusion:The method for determinning naringenin and hesperetin in plasma has been established,and the pharmacokinetic parameters can be instructive for clinic apllication.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:Elucidating the pharmacokinetic properties of Zhizhu Wan.Method:By using β-Glucuronidase,free hesperintin and naringenin were obtained from the hesperetin-glucronide naringenin-glucronaide in plasma,the contents of the two compounds in plasma was determined by HPLC.Results:T1/2(ka)/T1/2(ke)(h) for naringenin and hesperetin are 2.142±0.999/5.491±3.926 and 2.106±0.728/5.824±3.067 respectively,and the AUC(mg/L·h) value are 34.886±22.199 and 39.407±19.535 for naringenin and hesperetin respectively.Conclusion:The method for determinning naringenin and hesperetin in plasma has been established,and the pharmacokinetic parameters can be instructive for clinic apllication.
Key concepts: Hesperetin, Naringenin, Pharmacokinetics, Chemistry, Pharmacology, Human plasma, Oral administration, Chromatography